David Hafler

29PUBLICATIONS
200CO-AUTHORS
Medical virologyInnate immunityPredictive and prognostic markersEpidemiological modellingMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Mar 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Abigail Glascock, Cole Maguire, Hoang Van Phan

|Feb 23, 2026
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Jan 03, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Dec 25, 2025
Host Genetic Architecture between Epstein-Barr Virus Activity and Multiple Sclerosis Reveals Shared Pathways.

Yoshiaki Yasumizu, Namkwon Kim, Cyprien A Rivier

|Jun 06, 2025
Inflamed Microglia like Macrophages in the Central Nervous System of Prodromal Parkinson's Disease.

Le Zhang, Yoshiaki Yasumizu, M Elizabeth Deerhake

Pageof 5